secwatch.observer — SEC 8-K summary
======================================

Issuer:     CYTOKINETICS INC (CYTK)
CIK:        0001061983
Form:       8-K
Filed at:   2023-02-17T23:59:59+00:00
Accession:  0000950170-23-003230
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cytokinetics amends bylaws to add forum selection provisions for derivative and Securities Act claims
--------------------------------------------------------------------------------

- New Article X designates Delaware courts as exclusive forum for derivative suits, fiduciary duty, and corporate governance claims.
- Federal district courts set as exclusive forum for claims under the Securities Act of 1933.
- Board reserved the right to consent to an alternative forum in writing when deemed appropriate.
- Amendment effective February 14, 2023; prior Article X renumbered to Article XI.
- Purpose is to reduce risk of duplicative litigation and inconsistent outcomes across multiple forums.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1061983/000095017023003230/0000950170-23-003230-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1061983/000095017023003230/cytk-20230214.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-003230

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer